{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:39:02Z","timestamp":1788475142083,"version":"build-2803163510"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaad.2025.03.068","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T05:28:38Z","timestamp":1743226118000},"page":"197-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: A retrospective cohort database study"],"prefix":"10.1016","volume":"93","author":[{"given":"Zachary","family":"Neubauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2025.03.068_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.5534\/wjmh.190046","article-title":"Risk of depression after 5 alpha reductase inhibitor medication: meta-analysis","volume":"38","author":"Kim","year":"2020","journal-title":"World J Mens Health"},{"issue":"3","key":"10.1016\/j.jaad.2025.03.068_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/PSY.0000000000000784","article-title":"The association of 5\u03b1-reductase inhibitor with suicidality","volume":"82","author":"Kim","year":"2020","journal-title":"Psychosom Med"},{"issue":"12","key":"10.1016\/j.jaad.2025.03.068_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.48135","article-title":"Association of 5\u03b1-reductase inhibitors with dementia, depression, and suicide","volume":"5","author":"Garcia-Argibay","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jaad.2025.03.068_bib4","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1038\/s41598-023-32356-3","article-title":"Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study","volume":"13","author":"Laanani","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jaad.2025.03.068_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11255-015-0920-5","article-title":"Depressive symptoms in patients diagnosed with benign prostatic hyperplasia","volume":"47","author":"Pietrzyk","year":"2015","journal-title":"Int Urol Nephrol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T02:43:35Z","timestamp":1766112215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0190962225005419"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.068","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No increased risk of mood disorders in male androgenetic alopecia patients treated with dutasteride and finasteride: A retrospective cohort database study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}